Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm3.
Simon MutemboJane N MutangaKebby MusokotwaneLutangu AlishekeChristopher C WhalenPublished in: BMC infectious diseases (2016)
In patients with HIV-associated TB and CD4+ T cells above 350cells/mm3, treatment with cART reduced mortality for up to 4 years as compared to no cART and was associated with better retention in care.
Keyphrases
- endoplasmic reticulum stress
- induced apoptosis
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- hiv aids
- hiv infected patients
- mycobacterium tuberculosis
- hepatitis c virus
- hiv testing
- healthcare
- men who have sex with men
- palliative care
- south africa
- cell cycle arrest
- cell death
- coronary artery disease
- type diabetes
- cell proliferation
- cardiovascular events
- cardiovascular disease
- quality improvement
- pain management
- chronic pain